HappeningToo topic
Estradiol Transdermal reports
Browse community reports connected to Estradiol Transdermal. These reports can show that other people are describing similar experiences, but they do not prove that Estradiol Transdermal caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
50 problems
Abdominal Discomfort while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and abdominal discomfort appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and abdominal distension appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and abdominal pain upper appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and abdominal pain appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and acid reflux appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and alopecia appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and anxiety appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Application-site itching while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and application-site itching appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Application-site redness while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and application-site redness appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and back pain appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and chest discomfort appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and constipation appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and cough appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and decreased appetite appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and diarrhea appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and dizziness appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and dyspepsia appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and excessive sweating appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Eye Pain while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and eye pain appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and fatigue appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and feeling abnormal appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and flushing appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and headache appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and heart rate increased appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and hives appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hot Flush while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and hot flush appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and insomnia appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and itching appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and malaise appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and migraine appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and muscle spasms appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and muscular weakness appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and myalgia appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and nausea appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Night Sweats while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and night sweats appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and oropharyngeal pain appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and pain appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and palpitations appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and peripheral swelling appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and rash appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and shortness of breath appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and skin redness appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and sleepiness appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and tingling or pins and needles appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and tremor appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and vision blurred appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and vomiting appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and weakness appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and weight decreased appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Estradiol Transdermal
FDA FAERS contains adverse-event reports in which Estradiol Transdermal and weight increased appear together. This does not establish that Estradiol Transdermal caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →